A prospective study demonstrated that carriers of MSH2 mutations show the highest risk of developing adenomas and advanced adenomas, probably as a consequence of the association between germline MSH2 alterations and somatic APC gene mutations which may contribute to accelerate the colonic malignant transformation [49]. Here, MSH2 is linked to adenoma.